Product Code:161710
Published Date: Jul 14,2021
Pages: 94
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
According to this latest study, the 2021 growth of Filgrastim Injection will have significant change from previous year. By the most conservative estimates of global Filgrastim Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Filgrastim Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Filgrastim Injection market by product type, application, key manufacturers and key regions and countries. Segmentation by dosage form & strength type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7. 300mcg/mL (vial) 480mcg/1.6 mL (vial) 300mcg/0.5mL (Prefilled Syringe) 480mcg/0.8mL (Prefilled Syringe) Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8. Adult Use Pediatric Use Geriatric Use This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3. Accord Healthcare Teva Pharmaceuticals Pfizer Amgen Inc Novartis AG
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Filgrastim Injection Consumption 2016-2026
2.1.2 Filgrastim Injection Consumption CAGR by Region
2.2 Filgrastim Injection Segment by Dosage Form & Strength Type
2.2.1 300mcg/mL (vial)
2.2.2 480mcg/1.6 mL (vial)
2.2.3 300mcg/0.5mL (Prefilled Syringe)
2.2.4 480mcg/0.8mL (Prefilled Syringe)
2.3 Filgrastim Injection Sales by Dosage Form & Strength Type
2.3.1 Global Filgrastim Injection Sales Market Share by Dosage Form & Strength Type (2016-2021)
2.3.2 Global Filgrastim Injection Revenue and Market Share by Dosage Form & Strength Type (2016-2021)
2.3.3 Global Filgrastim Injection Sale Price by Dosage Form & Strength Type (2016-2021)
2.4 Filgrastim Injection Segment by Application
2.4.1 Adult Use
2.4.2 Pediatric Use
2.4.3 Geriatric Use
2.5 Filgrastim Injection Sales by Application
2.5.1 Global Filgrastim Injection Sale Market Share by Application (2016-2021)
2.5.2 Global Filgrastim Injection Revenue and Market Share by Application (2016-2021)
2.5.3 Global Filgrastim Injection Sale Price by Application (2016-2021)
3 Global Filgrastim Injection by Company
3.1 Global Filgrastim Injection Sales Market Share by Company
3.1.1 Global Filgrastim Injection Sales by Company (2019-2021)
3.1.2 Global Filgrastim Injection Sales Market Share by Company (2019-2021)
3.2 Global Filgrastim Injection Revenue Market Share by Company
3.2.1 Global Filgrastim Injection Revenue by Company (2019-2021)
3.2.2 Global Filgrastim Injection Revenue Market Share by Company (2019-2021)
3.3 Global Filgrastim Injection Sale Price by Company
3.4 Global Manufacturers Filgrastim Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Filgrastim Injection Product Location Distribution
3.4.2 Players Filgrastim Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Filgrastim Injection by Region
4.1 Global Filgrastim Injection by Region
4.1.1 Global Filgrastim Injection Sales by Region
4.1.2 Global Filgrastim Injection Revenue by Region
4.2 Americas Filgrastim Injection Sales Growth
4.3 APAC Filgrastim Injection Sales Growth
4.4 Europe Filgrastim Injection Sales Growth
4.5 Middle East & Africa Filgrastim Injection Sales Growth
5 Americas
5.1 Americas Filgrastim Injection Sales by Country
5.1.1 Americas Filgrastim Injection Sales by Country (2016-2021)
5.1.2 Americas Filgrastim Injection Revenue by Country (2016-2021)
5.2 Americas Filgrastim Injection Sales by Dosage Form & Strength Type
5.3 Americas Filgrastim Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Filgrastim Injection Sales by Region
6.1.1 APAC Filgrastim Injection Sales by Region (2016-2021)
6.1.2 APAC Filgrastim Injection Revenue by Region (2016-2021)
6.2 APAC Filgrastim Injection Sales by Dosage Form & Strength Type
6.3 APAC Filgrastim Injection Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Filgrastim Injection by Country
7.1.1 Europe Filgrastim Injection Sales by Country (2016-2021)
7.1.2 Europe Filgrastim Injection Revenue by Country (2016-2021)
7.2 Europe Filgrastim Injection Sales by Dosage Form & Strength Type
7.3 Europe Filgrastim Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Filgrastim Injection by Country
8.1.1 Middle East & Africa Filgrastim Injection Sales by Country (2016-2021)
8.1.2 Middle East & Africa Filgrastim Injection Revenue by Country (2016-2021)
8.2 Middle East & Africa Filgrastim Injection Sales by Dosage Form & Strength Type
8.3 Middle East & Africa Filgrastim Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Filgrastim Injection Distributors
10.3 Filgrastim Injection Customer
11 Global Filgrastim Injection Market Forecast
11.1 Global Filgrastim Injection Forecast by Region
11.1.1 Global Filgrastim Injection Forecast by Regions (2021-2026)
11.2.2 Global Filgrastim Injection Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Filgrastim Injection Forecast by Dosage Form & Strength Type
11.7 Global Filgrastim Injection Forecast by Application
12 Key Players Analysis
12.1 Accord Healthcare
12.1.1 Accord Healthcare Company Information
12.1.2 Accord Healthcare Filgrastim Injection Product Offered
12.1.3 Accord Healthcare Filgrastim Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Accord Healthcare Main Business Overview
12.1.5 Accord Healthcare Latest Developments
12.2 Teva Pharmaceuticals
12.2.1 Teva Pharmaceuticals Company Information
12.2.2 Teva Pharmaceuticals Filgrastim Injection Product Offered
12.2.3 Teva Pharmaceuticals Filgrastim Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Teva Pharmaceuticals Main Business Overview
12.2.5 Teva Pharmaceuticals Latest Developments
12.3 Pfizer
12.3.1 Pfizer Company Information
12.3.2 Pfizer Filgrastim Injection Product Offered
12.3.3 Pfizer Filgrastim Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Pfizer Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 Amgen Inc
12.4.1 Amgen Inc Company Information
12.4.2 Amgen Inc Filgrastim Injection Product Offered
12.4.3 Amgen Inc Filgrastim Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Amgen Inc Main Business Overview
12.4.5 Amgen Inc Latest Developments
12.5 Novartis AG
12.5.1 Novartis AG Company Information
12.5.2 Novartis AG Filgrastim Injection Product Offered
12.5.3 Novartis AG Filgrastim Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Novartis AG Main Business Overview
12.5.5 Novartis AG Latest Developments
13 Research Findings and Conclusion
List of Tables Table 1. Filgrastim Injection Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of 300mcg/mL (vial) Table 3. Major Players of 480mcg/1.6 mL (vial) Table 4. Major Players of 300mcg/0.5mL (Prefilled Syringe) Table 5. Major Players of 480mcg/0.8mL (Prefilled Syringe) Table 6. Global Filgrastim Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL) Table 7. Global Filgrastim Injection Sales Market Share by Dosage Form & Strength Type (2016-2021) Table 8. Global Filgrastim Injection Revenue by Dosage Form & Strength Type (2016-2021) & ($ million) Table 9. Global Filgrastim Injection Revenue Market Share by Dosage Form & Strength Type (2016-2021) Table 10. Global Filgrastim Injection Sale Price by Dosage Form & Strength Type (2016-2021) Table 11. Global Filgrastim Injection Sales by Application (2016-2021) & (KL) Table 12. Global Filgrastim Injection Sales Market Share by Application (2016-2021) Table 13. Global Filgrastim Injection Value by Application (2016-2021) Table 14. Global Filgrastim Injection Revenue Market Share by Application (2016-2021) Table 15. Global Filgrastim Injection Sale Price by Application (2016-2021) Table 16. Global Filgrastim Injection Sales by Company (2019-2021) & (KL) Table 17. Global Filgrastim Injection Sales Market Share by Company (2019-2021) Table 18. Global Filgrastim Injection Revenue by Company (2019-2021) ($ Millions) Table 19. Global Filgrastim Injection Revenue Market Share by Company (2019-2021) Table 20. Global Filgrastim Injection Sale Price by Company (2019-2021) Table 21. Key Manufacturers Filgrastim Injection Producing Area Distribution and Sales Area Table 22. Players Filgrastim Injection Products Offered Table 23. Filgrastim Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Filgrastim Injection Sales by Region (2016-2021) (KL) Table 27. Global Filgrastim Injection Sales Market Share by Region (2016-2021) Table 28. Global Filgrastim Injection Revenue by Region (2016-2021) & ($ Millions) Table 29. Global Filgrastim Injection Revenue Market Share by Region (2016-2021) Table 30. Americas Filgrastim Injection Sales by Country (2016-2021) & (KL) Table 31. Americas Filgrastim Injection Sales Market Share by Country (2016-2021) Table 32. Americas Filgrastim Injection Revenue by Country (2016-2021) & ($ Millions) Table 33. Americas Filgrastim Injection Revenue Market Share by Country (2016-2021) Table 34. Americas Filgrastim Injection Sales by Type (2016-2021) & (KL) Table 35. Americas Filgrastim Injection Sales Market Share by Dosage Form & Strength Type (2016-2021) Table 36. Americas Filgrastim Injection Sales by Application (2016-2021) & (KL) Table 37. Americas Filgrastim Injection Sales Market Share by Application (2016-2021) Table 38. APAC Filgrastim Injection Sales by Region (2016-2021) & (KL) Table 39. APAC Filgrastim Injection Sales Market Share by Region (2016-2021) Table 40. APAC Filgrastim Injection Revenue by Region (2016-2021) & ($ Millions) Table 41. APAC Filgrastim Injection Revenue Market Share by Region (2016-2021) Table 42. APAC Filgrastim Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL) Table 43. APAC Filgrastim Injection Sales Market Share by Dosage Form & Strength Type (2016-2021) Table 44. APAC Filgrastim Injection Sales by Application (2016-2021) & (KL) Table 45. APAC Filgrastim Injection Sales Market Share by Application (2016-2021) Table 46. Europe Filgrastim Injection Sales by Country (2016-2021) & (KL) Table 47. Europe Filgrastim Injection Sales Market Share by Country (2016-2021) Table 48. Europe Filgrastim Injection Revenue by Country (2016-2021) & ($ Millions) Table 49. Europe Filgrastim Injection Revenue Market Share by Country (2016-2021) Table 50. Europe Filgrastim Injection Sales by Type (2016-2021) & (KL) Table 51. Europe Filgrastim Injection Sales Market Share by Dosage Form & Strength Type (2016-2021) Table 52. Europe Filgrastim Injection Sales by Application (2016-2021) & (KL) Table 53. Europe Filgrastim Injection Sales Market Share by Application (2016-2021) Table 54. Middle East & Africa Filgrastim Injection Sales by Country (2016-2021) & (KL) Table 55. Middle East & Africa Filgrastim Injection Sales Market Share by Country (2016-2021) Table 56. Middle East & Africa Filgrastim Injection Revenue by Country (2016-2021) & ($ Millions) Table 57. Middle East & Africa Filgrastim Injection Revenue Market Share by Country (2016-2021) Table 58. Middle East & Africa Filgrastim Injection Sales by Dosage Form & Strength Type (2016-2021) & (KL) Table 59. Middle East & Africa Filgrastim Injection Sales Market Share by Dosage Form & Strength Type (2016-2021) Table 60. Middle East & Africa Filgrastim Injection Sales by Application (2016-2021) & (KL) Table 61. Middle East & Africa Filgrastim Injection Sales Market Share by Application (2016-2021) Table 62. Key and Potential Regions of Filgrastim Injection Table 63. Key Application and Potential Industries of Filgrastim Injection Table 64. Key Challenges of Filgrastim Injection Table 65. Key Trends of Filgrastim Injection Table 66. Filgrastim Injection Distributors List Table 67. Filgrastim Injection Customer List Table 68. Global Filgrastim Injection Sales Forecast by Region (2021-2026) & (KL) Table 69. Global Filgrastim Injection Consumption Market Forecast by Region Table 70. Global Filgrastim Injection Revenue Forecast by Region (2021-2026) & ($ millions) Table 71. Global Filgrastim Injection Revenue Market Share Forecast by Region (2021-2026) Table 72. Americas Filgrastim Injection Sales Forecast by Country (2021-2026) & (KL) Table 73. Americas Filgrastim Injection Revenue Forecast by Country (2021-2026) & ($ millions) Table 74. APAC Filgrastim Injection Sales Forecast by Region (2021-2026) & (KL) Table 75. APAC Filgrastim Injection Revenue Forecast by Region (2021-2026) & ($ millions) Table 76. Europe Filgrastim Injection Sales Forecast by Country (2021-2026) & (KL) Table 77. Europe Filgrastim Injection Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Middle East & Africa Filgrastim Injection Sales Forecast by Country (2021-2026) & (KL) Table 79. Middle East & Africa Filgrastim Injection Revenue Forecast by Country (2021-2026) & ($ millions) Table 80. Global Filgrastim Injection Sales Forecast by Dosage Form & Strength Type (2021-2026) & (KL) Table 81. Global Filgrastim Injection Sales Market Share Forecast by Dosage Form & Strength Type (2021-2026) Table 82. Global Filgrastim Injection Revenue Forecast by Dosage Form & Strength Type (2021-2026) & ($ Millions) Table 83. Global Filgrastim Injection Revenue Market Share Forecast by Dosage Form & Strength Type (2021-2026) Table 84. Global Filgrastim Injection Sales Forecast by Application (2021-2026) & (KL) Table 85. Global Filgrastim Injection Sales Market Share Forecast by Application (2021-2026) Table 86. Global Filgrastim Injection Revenue Forecast by Application (2021-2026) & ($ Millions) Table 87. Global Filgrastim Injection Revenue Market Share Forecast by Application (2021-2026) Table 88. Accord Healthcare Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors Table 89. Accord Healthcare Filgrastim Injection Product Offered Table 90. Accord Healthcare Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2021E) Table 91. Accord Healthcare Main Business Table 92. Accord Healthcare Latest Developments Table 93. Teva Pharmaceuticals Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors Table 94. Teva Pharmaceuticals Filgrastim Injection Product Offered Table 95. Teva Pharmaceuticals Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2021E) Table 96. Teva Pharmaceuticals Main Business Table 97. Teva Pharmaceuticals Latest Developments Table 98. Pfizer Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors Table 99. Pfizer Filgrastim Injection Product Offered Table 100. Pfizer Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2021E) Table 101. Pfizer Main Business Table 102. Pfizer Latest Developments Table 103. Amgen Inc Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors Table 104. Amgen Inc Filgrastim Injection Product Offered Table 105. Amgen Inc Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2021E) Table 106. Amgen Inc Main Business Table 107. Amgen Inc Latest Developments Table 108. Novartis AG Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors Table 109. Novartis AG Filgrastim Injection Product Offered Table 110. Novartis AG Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2021E) Table 111. Novartis AG Main Business Table 112. Novartis AG Latest Developments List of Figures Figure 1. Picture of Filgrastim Injection Figure 2. Filgrastim Injection Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Filgrastim Injection Sales Growth Rate 2016-2026 (KL) Figure 7. Global Filgrastim Injection Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Filgrastim Injection Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of 300mcg/mL (vial) Figure 10. Product Picture of 480mcg/1.6 mL (vial) Figure 11. Product Picture of 300mcg/0.5mL (Prefilled Syringe) Figure 12. Product Picture of 480mcg/0.8mL (Prefilled Syringe) Figure 13. Global Filgrastim Injection Sales Market Share by Dosage Form & Strength Type in 2020 Figure 14. Global Filgrastim Injection Revenue Market Share by Dosage Form & Strength Type (2016-2021) Figure 15. Filgrastim Injection Consumed in Adult Use Figure 16. Global Filgrastim Injection Market: Adult Use (2016-2021) & (KL) Figure 17. Filgrastim Injection Consumed in Pediatric Use Figure 18. Global Filgrastim Injection Market: Pediatric Use (2016-2021) & (KL) Figure 19. Filgrastim Injection Consumed in Geriatric Use Figure 20. Global Filgrastim Injection Market: Geriatric Use (2016-2021) & (KL) Figure 21. Global Filgrastim Injection Sales Market Share by Application (2016-2021) Figure 22. Global Filgrastim Injection Revenue Market Share by Application in 2020 Figure 23. Filgrastim Injection Revenue Market by Company in 2020 ($ Million) Figure 24. Global Filgrastim Injection Revenue Market Share by Company in 2020 Figure 25. Global Filgrastim Injection Sales Market Share by Regions (2016-2021) Figure 26. Global Filgrastim Injection Revenue Market Share by Region in 2020 Figure 27. Americas Filgrastim Injection Sales 2016-2021 (KL) Figure 28. Americas Filgrastim Injection Revenue 2016-2021 ($ Millions) Figure 29. APAC Filgrastim Injection Sales 2016-2021 (KL) Figure 30. APAC Filgrastim Injection Revenue 2016-2021 ($ Millions) Figure 31. Europe Filgrastim Injection Sales 2016-2021 (KL) Figure 32. Europe Filgrastim Injection Revenue 2016-2021 ($ Millions) Figure 33. Middle East & Africa Filgrastim Injection Sales 2016-2021 (KL) Figure 34. Middle East & Africa Filgrastim Injection Revenue 2016-2021 ($ Millions) Figure 35. Americas Filgrastim Injection Sales Market Share by Country in 2020 Figure 36. Americas Filgrastim Injection Revenue Market Share by Country in 2020 Figure 37. Americas Filgrastim Injection Sales Market Share by Dosage Form & Strength Type in 2020 Figure 38. Americas Filgrastim Injection Sales Market Share by Application in 2020 Figure 39. United States Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 40. Canada Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 41. Mexico Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 42. Brazil Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 43. APAC Filgrastim Injection Sales Market Share by Region in 2020 Figure 44. APAC Filgrastim Injection Revenue Market Share by Regions in 2020 Figure 45. APAC Filgrastim Injection Sales Market Share by Dosage Form & Strength Type in 2020 Figure 46. APAC Filgrastim Injection Sales Market Share by Application in 2020 Figure 47. China Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 48. Japan Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 49. Korea Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 50. Southeast Asia Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 51. India Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 52. Australia Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 53. Europe Filgrastim Injection Sales Market Share by Country in 2020 Figure 54. Europe Filgrastim Injection Revenue Market Share by Country in 2020 Figure 55. Europe Filgrastim Injection Sales Market Share by Dosage Form & Strength Type in 2020 Figure 56. Europe Filgrastim Injection Sales Market Share by Application in 2020 Figure 57. Germany Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 58. France Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 59. UK Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 60. Italy Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 61. Russia Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 62. Middle East & Africa Filgrastim Injection Sales Market Share by Country in 2020 Figure 63. Middle East & Africa Filgrastim Injection Revenue Market Share by Country in 2020 Figure 64. Middle East & Africa Filgrastim Injection Sales Market Share by Dosage Form & Strength Type in 2020 Figure 65. Middle East & Africa Filgrastim Injection Sales Market Share by Application in 2020 Figure 66. Egypt Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 67. South Africa Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 68. Israel Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 69. Turkey Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 70. GCC Country Filgrastim Injection Revenue Growth 2016-2021 ($ Millions) Figure 71. Channels of Distribution Figure 72. Distributors Profiles
Accord Healthcare Teva Pharmaceuticals Pfizer Amgen Inc Novartis AG
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape
RELATED REPORTS
Jan
2024
Global Filgrastim Injection Market Growth 2024-2030
Pages: 94|Category: PHARMA & HEALTHCARE
According to our LPI (LP Information) latest study, the global Filgrastim Injection market size was valued at US$ million in 2023. With growing demand in downstream market, the Filgrastim Injection is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
$3660.00